{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:56:50Z","timestamp":1791028610380,"version":"4.1.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/1477-7827-1-111","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T12:41:21Z","timestamp":1071578481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Thrombophilia and pregnancy"],"prefix":"10.1186","volume":"1","author":[{"given":"Michael J","family":"Kupferminc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,11,14]]},"reference":[{"key":"111_CR1","first-page":"139","volume":"24","author":"B Dahlback","year":"1994","unstructured":"Dahlback B: Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis. 1994, 24: 139-151.","journal-title":"Haemostasis"},{"key":"111_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994, 369: 64-67. 10.1038\/369064a0.","journal-title":"Nature"},{"key":"111_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJM199402243300801","volume":"330","author":"PJ Svensson","year":"1994","unstructured":"Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994, 330: 517-552. 10.1056\/NEJM199402243300801.","journal-title":"N Engl J Med"},{"key":"111_CR4","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996, 88: 3698-3703.","journal-title":"Blood"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJM199806183382502","volume":"338","author":"I Maertinelli","year":"1988","unstructured":"Maertinelli I, Sagghi E, Landi G, Taioli E, Duca F, Mannucci PM: High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in the user of oral contraceptives. N Engl J Med. 1988, 338: 1793-1797. 10.1056\/NEJM199806183382502.","journal-title":"N Engl J Med"},{"key":"111_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995, 10: 111-113.","journal-title":"Nat Genet"},{"key":"111_CR7","first-page":"35","volume":"58","author":"LA Kluijtmans","year":"1996","unstructured":"Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van OostBA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocystinemia: a common mutation in the methylene-tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996, 58: 35-41.","journal-title":"Am J Hum Genet"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nm0496-386","volume":"2","author":"KS McCully","year":"1996","unstructured":"McCully KS: Homocysteine and vascular disease. Nat Med. 1996, 2: 386-389.","journal-title":"Nat Med"},{"key":"111_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0735-1097(95)00508-0","volume":"27","author":"EL Mayer","year":"1996","unstructured":"Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996, 27: 517-527. 10.1016\/0735-1097(95)00508-0.","journal-title":"J Am Coll Cardiol"},{"key":"111_CR10","first-page":"1324","volume":"56","author":"G Sebastio","year":"1995","unstructured":"Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G: The molecular basis of homocysteinuria due to cystathionie beta-synthase deficiency in Italian families, and report for four novel mutations. Am J Hum Genet. 1995, 56: 1324-1333.","journal-title":"Am J Hum Genet"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","volume":"161","author":"JM Roberts","year":"1989","unstructured":"Roberts JM, Taylor RN, Musici TJ, Rodgers GM, Hubel CA, McLaughlin MK: Preeclampsia an endothelial cell disorder. Am J Obstet Gynecol. 1989, 161: 1200-1204.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/0002-9378(95)91330-0","volume":"173","author":"CM Salafia","year":"1995","unstructured":"Salafia CM, Pezzulo JC, Lopez-Zeno JA, Minior VK, Vintzileos AM: Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol. 1995, 173: 1079-1105.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0002-9378(89)90392-X","volume":"161","author":"DR Shanklin","year":"1989","unstructured":"Shanklin DR, Sibai BM: Ultrastructural aspects of preeclampsia. Am J Obstet Gynecol. 1989, 161: 735-741.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0002-9378(87)80172-2","volume":"157","author":"TY Khong","year":"1987","unstructured":"Khong TY, Pearce JM, Robertson WB: Acute atherosis in preeclampsia: maternal determination and fetal outcome in the presence of the lesion. Am J Obstet Gynecol. 1987, 157: 360-363.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0002-9378(95)91325-4","volume":"173","author":"CM Salafia","year":"1995","unstructured":"Salafia CM, Minior VK, Pezzulo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM: Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol. 1995, 173: 1049-1057.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR16","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","volume":"353","author":"IA Greer","year":"1999","unstructured":"Greer IA: Thrombosis in Pregnancy: Maternal and Fetal Issues. Lancet. 1999, 353: 1258-1265. 10.1016\/S0140-6736(98)10265-9.","journal-title":"Lancet"},{"key":"111_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0038-1657542","volume":"78","author":"U Seligsohn","year":"1997","unstructured":"Seligsohn U, Zivelin A: Thrombophilia As a Multigenic Disorder. Thromb Haemost. 1997, 78: 297-301.","journal-title":"Thromb Haemost"},{"key":"111_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/NEJM200002103420602","volume":"342","author":"A Gerhardt","year":"2000","unstructured":"Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB: Prothrombin and Factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000, 342: 374-380. 10.1056\/NEJM200002103420602.","journal-title":"N Engl J Med"},{"key":"111_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJM200002103420610","volume":"342","author":"IA Greer","year":"2000","unstructured":"Greer IA: The Challenge of Thrombophilia in Maternal-Fetal Medicine. N Engl J Med. 2000, 342: 424-425. 10.1056\/NEJM200002103420610.","journal-title":"N Engl J Med"},{"key":"111_CR20","first-page":"609","volume-title":"In: Maternal Fetal Medicine: Principles and Practice","author":"JR Green","year":"1994","unstructured":"Green JR: Placenta previa and abruptio placentae. In: Maternal Fetal Medicine: Principles and Practice. Edited by: Creasy RK, Resnik R. 1994, Philadelphia: W.B. Saunders, 609-610."},{"key":"111_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1056\/NEJM199110103251503","volume":"325","author":"C Infante-Rievard","year":"1991","unstructured":"Infante-Rievard C, David M, Gauthier R, Ribard GE: Lupus anticoagulants, anticardiolipin antibodies and fetal loss. N Engl J Med. 1991, 325: 1063-1066.","journal-title":"N Engl J Med"},{"key":"111_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0002-9378(98)70160-7","volume":"179","author":"GA Dekker","year":"1998","unstructured":"Dekker GA, Sibai BM: Etiology and pathophysiology of preeclampsia Current concepts. AJOG Review. Am J Obstet Gynecol. 1998, 179: 1359-1375.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0029-7844(01)01621-0","volume":"98","author":"A Many","year":"2001","unstructured":"Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ: Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol. 2001, 98: 1041-1044. 10.1016\/S0029-7844(01)01621-0.","journal-title":"Obstet Gynecol"},{"key":"111_CR24","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","volume":"15","author":"HA Mousa","year":"2000","unstructured":"Mousa HA, Alfirevic Z: Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod. 2000, 15: 1830-1833. 10.1093\/humrep\/15.8.1830.","journal-title":"Hum Reprod"},{"key":"111_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/plac.2001.0785","volume":"23","author":"JM Sikkema","year":"2002","unstructured":"Sikkema JM, Franx A, Bruinse HW, van der Wijk NG, de Valk HW, Nikkels PG: Placental pathology in early onset pre-eclampsia and intra-uterinegrowth restriction in women with and without thrombophilia. Placenta. 2002, 23: 337-342. 10.1053\/plac.2001.0785.","journal-title":"Placenta"},{"key":"111_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/(SICI)1520-6661(199811\/12)7:6<277::AID-MFM5>3.0.CO;2-3","volume":"7","author":"F Arias","year":"1998","unstructured":"Arias F, Romero R, Joist H, Kraus FT: Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med. 1998, 7: 277-286.","journal-title":"J Matern Fetal Med"},{"key":"111_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","volume":"68","author":"D Alarcon-Segovia","year":"1989","unstructured":"Alarcon-Segovia D, Delete M, Oria CV, Sanchez-Guerrero J, Gomet-Pacheco L, Cabiedes I, Fernandez L, Ponce de Leon S: Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine. 1989, 68: 353-365.","journal-title":"Medicine"},{"key":"111_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","volume":"68","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GR: The \"primary\" anti-phospholipid syndrome: major clinical and serological features. Medicine. 1989, 68: 366-374.","journal-title":"Medicine"},{"key":"111_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/26.5.324","volume":"26","author":"EN Harris","year":"1987","unstructured":"Harris EN: Syndrome of the black swan. Br J Rheumatol. 1987, 26: 324-326.","journal-title":"Br J Rheumatol"},{"key":"111_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJM199707173370303","volume":"337","author":"JH Rand","year":"1997","unstructured":"Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, Harpel PC: Pregnancy loss in the antiphospholid-antibody syndrome \u2013 a possible thrombogenic mechanism. N Engl J Med. 1997, 337: 154-160. 10.1056\/NEJM199707173370303.","journal-title":"N Engl J Med"},{"key":"111_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0029-7844(97)00065-3","volume":"89","author":"DW Branch","year":"1997","unstructured":"Branch DW, Silver RM, Pierangeli S, van Leeuwen I, Harris EN: Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and anliphospholipid syndrome. Obstet Gynecol. 1997, 89: 549-555. 10.1016\/S0029-7844(97)00065-3.","journal-title":"Obstet Gynecol"},{"key":"111_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1471-0528.1994.tb13073.x","volume":"101","author":"MA MacLean","year":"1994","unstructured":"MacLean MA, Cumming GP, McCall F, Walker ID, Wallter JJ: The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. BJOG. 1994, 101: 103-110.","journal-title":"BJOG"},{"key":"111_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/ard.50.8.553","volume":"50","author":"HJ Out","year":"1991","unstructured":"Out HJ, Bruinse HW, Christiaens GCML, van Vliet M, Meilof IF, de Groot PG, Smeenk RJ, Derksen RH: Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis. 1991, 50: 553-557.","journal-title":"Ann Rheum Dis"},{"key":"111_CR34","first-page":"854","volume":"77","author":"F Parazzini","year":"1991","unstructured":"Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S: Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol. 1991, 77: 854-858.","journal-title":"Obstet Gynecol"},{"key":"111_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.1780300601","volume":"30","author":"M Petri","year":"1987","unstructured":"Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D: Antinuclear antibody, lupus antiroagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled prospective study of forty-four women. Arthritis Rheum. 1987, 30: 601-606.","journal-title":"Arthritis Rheum"},{"key":"111_CR36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","volume":"66","author":"DL Yetman","year":"1996","unstructured":"Yetman DL, Kutteh WH: Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril. 1996, 66: 540-546.","journal-title":"Fertil Steril"},{"key":"111_CR37","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","volume":"10","author":"RS Rai","year":"1995","unstructured":"Rai RS, Clifford K, Cohen H, Regan L: High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod. 1995, 10: 3301-3304.","journal-title":"Hum Reprod"},{"key":"111_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0029-7844(95)00498-X","volume":"87","author":"BT Oshiro","year":"1996","unstructured":"Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW: Antiphospholipid antibodies and fetal death. Obstet Gynecol. 1996, 87: 489-493. 10.1016\/0029-7844(95)00498-X.","journal-title":"Obstet Gynecol"},{"key":"111_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/00016349409006249","volume":"73","author":"L Bocciolone","year":"1994","unstructured":"Bocciolone L, Meroni P, Parazrini F, Tincani A, Radici E, Tarantini M, Rossi E, Bianchi C, Mezzanotte C, D'Angelo A: Antiphospholipid antibodies and risk of intrauterine late fetal death. Acta Obstet Gynecol Scand. 1994, 73: 389-392.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"111_CR40","first-page":"614","volume":"80","author":"DW Branch","year":"1992","unstructured":"Branch DW, Silver RM, Blackwell L, Reading JC, Scott JR: Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992, 80: 614-620.","journal-title":"Obstet Gynecol"},{"key":"111_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1471-0528.1987.tb03162.x","volume":"94","author":"RAH Scott","year":"1987","unstructured":"Scott RAH: Anti-cardiolipin antibodies and pre-eclampsia. BJOG. 1987, 94: 604-605.","journal-title":"BJOG"},{"key":"111_CR42","first-page":"541","volume":"73","author":"DW Branch","year":"1989","unstructured":"Branch DW, Andres R, Digre KB, Rote NS, Scott JR: The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 1989, 73: 541-545.","journal-title":"Obstet Gynecol"},{"key":"111_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","volume":"173","author":"GA Dekker","year":"1995","unstructured":"Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, Blomberg von BME, Jakobs C, Geijn van HP: Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 1995, 173: 1042-1048.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR44","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","volume":"180","author":"MG Pampus van","year":"1999","unstructured":"Pampus van MG, van MP, Dekker GA, Wolf HW, Huijgens PC, Koopman MMW, Blomberg BME, von B\u00fcller HR: High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol. 1999, 180: 1146-1150.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-0528.1993.tb15105.x","volume":"100","author":"NS Pattison","year":"1993","unstructured":"Pattison NS, Chamley LW, McKay W, Liggins GC, Butler WS: Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. BJOG. 1993, 100: 909-913.","journal-title":"BJOG"},{"key":"111_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0029-7844(95)80015-8","volume":"86","author":"M Yasuda","year":"1995","unstructured":"Yasuda M, Takakuwa K, Tokunaga A, Tanaka K: Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol. 1995, 86: 555-559. 10.1016\/0029-7844(95)00247-O.","journal-title":"Obstet Gynecol"},{"key":"111_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM199901073400102","volume":"340","author":"MJ Kupferminc","year":"1999","unstructured":"Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB: Increased frequency of the genetic thrombophilia in women with complications of pregnancy. N Eng J Med. 1999, 340: 9-13. 10.1056\/NEJM199901073400102.","journal-title":"N Eng J Med"},{"key":"111_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/10641959009012935","volume":"B9","author":"SB Rajah","year":"1990","unstructured":"Rajah SB, Moodley J, Pudifin D, Duursma J: Anticardiolipin antibodies in hypertensive emergencies. Clin Exp Hypertens B. Hypertension in Pregnancy. 1990, B9: 267-271.","journal-title":"Hypertension in Pregnancy"},{"key":"111_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0002-9378(11)91619-6","volume":"167","author":"HJ Out","year":"1992","unstructured":"Out HJ, Bruinse HW, Christiaens GCML, Van Vliet M, De Groot PG, Nieuwenhuis HK, Derksen RHWM: A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol. 1992, 167: 20-26.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.7326\/0003-4819-120-6-199403150-00004","volume":"120","author":"A Lynch","year":"1994","unstructured":"Lynch A, Marlar R, Murphy J, Davila G, Santos M, Rutledge J, Emlen Wl: Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med. 1994, 120: 470-475.","journal-title":"Ann Intern Med"},{"key":"111_CR51","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJM198511213132104","volume":"313","author":"DW Branch","year":"1985","unstructured":"Branch DW, Scott JR, Kochenour NK, Hershgold E: Obstetric complications associated with lupus anticoagulant. N Engl J Med. 1985, 313: 1322-1326.","journal-title":"N Engl J Med"},{"key":"111_CR52","first-page":"970","volume":"82","author":"A Caruso","year":"1993","unstructured":"Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Manusco S: Pregnancy outcome in relation to uterine artery now velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol. 1993, 82: 970-976.","journal-title":"Obstet Gynecol"},{"key":"111_CR53","first-page":"131","volume":"14","author":"F Lima","year":"1996","unstructured":"Lima F, Khamashta MA, Buchanan NMM, Kerslake S, Hunt BI, Hughes GRV: A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 1996, 14: 131-136.","journal-title":"Clin Exp Rheumatol"},{"key":"111_CR54","first-page":"1108","volume":"78","author":"WJ Polzin","year":"1991","unstructured":"Polzin WJ, Kopelman JN, Robinson RD, Read JA, Brady K: The association of antiphospholipid antibodies with pregnancy complicated by fetal growth restriction. Obstet Gynecol. 1991, 78: 1108-1111.","journal-title":"Obstet Gynecol"},{"key":"111_CR55","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","volume":"175","author":"DS Dizon-Townson","year":"1996","unstructured":"Dizon-Townson DS, Nelson LM, Easton K, Ward K: The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol. 1996, 175: 902-5.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR56","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1399-0004.1998.tb02599.x","volume":"53","author":"B Nagy","year":"1998","unstructured":"Nagy B, T\u00f3th T, Rig\u00f3 JJR, Kar\u00e1di I, Romics L, Papp Z: Detection of factor v Leiden in severe pre-eclamptic Hungarian women. Clin genet. 1998, 53: 478-481.","journal-title":"Clin genet"},{"key":"111_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1081\/PRG-100100132","volume":"19","author":"J Rigo Jr","year":"2000","unstructured":"Rigo J, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z: Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy. 2000, 19: 163-172. 10.1081\/PRG-100100132.","journal-title":"Hypertens Pregnancy"},{"key":"111_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0029-7844(00)00861-9","volume":"96","author":"MJ Kupferminc","year":"2000","unstructured":"Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB: Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol. 2000, 96: 45-49. 10.1016\/S0029-7844(00)00861-9.","journal-title":"Obstet Gynecol"},{"key":"111_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0049-3848(00)00312-1","volume":"100","author":"GF von Tempelhoff","year":"2000","unstructured":"von Tempelhoff GF, Heilmann L, Spanuth E, Kunzmann E, Hommel G: Incidence of the factor V Leiden mutation, coagulation inhibitor deficiency, and elevated antiphospholipid antibodies in patients with pre-eclampsia or HELLP-syndrome. Thromb Res. 2000, 100: 363-365. 10.1016\/S0049-3848(00)00312-1.","journal-title":"Thromb Res"},{"key":"111_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1067\/mob.2001.114691","volume":"185","author":"JC Livingston","year":"2001","unstructured":"Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM: Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol. 2001, 185: 153-157. 10.1067\/mob.2001.114691.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0029-7844(00)00896-6","volume":"96","author":"H Laivuori","year":"2000","unstructured":"Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K: 677 T polymorphism of the MTHFR gene and pre-eclampsia. Obstet Gynecol. 2000, 96: 277-280. 10.1016\/S0029-7844(00)00896-6.","journal-title":"Obstet Gynecol"},{"key":"111_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000010326","volume":"50","author":"JR Higgins","year":"2000","unstructured":"Higgins JR, Kaiser T, Moses EK, North R, Brennecke SP: Prothrombin G20210A mutation: is it associated with pre-eclampsia?. Gynecol Obstet Invest. 2000, 50: 254-256. 10.1159\/000010326.","journal-title":"Gynecol Obstet Invest"},{"key":"111_CR63","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1034\/j.1600-0412.2000.079011963.x","volume":"79","author":"MJ Kupferminc","year":"2000","unstructured":"Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A: High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and 2nd trimester loss. Acta Obstet Gynecol Scand. 2000, 79: 963-967. 10.1034\/j.1600-0412.2000.079011963.x.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"111_CR64","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0029-7844(98)00208-7","volume":"92","author":"T Krauss","year":"1998","unstructured":"Krauss T, Augustin HG, Osmers R, Meden H, Unterhalt M, Kuhn W: Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol. 1998, 92: 457-460. 10.1016\/S0029-7844(98)00208-7.","journal-title":"Obstet Gynecol"},{"key":"111_CR65","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1055\/s-0038-1656110","volume":"77","author":"E Grandone","year":"1997","unstructured":"Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G: Factor V Leiden, C >T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost. 1997, 77: 1052-1054.","journal-title":"Thromb Haemost"},{"key":"111_CR66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0037-1614475","volume":"81","author":"E Grandone","year":"1999","unstructured":"Grandone E, Margaglione M, Colaizzo D, Cappucci G, Scianname N, Montanaro S, Paladini D, Martinelli P, Di Minno G: Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost. 1999, 81: 349-352.","journal-title":"Thromb Haemost"},{"key":"111_CR67","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/01.HYP.33.6.1338","volume":"33","author":"KM Shaughnessy","year":"1999","unstructured":"Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH: Factor V Leiden and thermolable methylenetetrahydrofolate reductase gene variants in an east Anglian preeclampsia cohort. Hypertension. 1999, 33: 1338-1341.","journal-title":"Hypertension"},{"key":"111_CR68","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/jmg.34.6.525","volume":"34","author":"S Sohda","year":"1997","unstructured":"Sohda S, Arinami T, Hamada HM, Yamada N, Hamaguchi H, Kubo T: Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet. 1997, 34: 525-526.","journal-title":"J Med Genet"},{"key":"111_CR69","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0002-9378(97)70515-5","volume":"176","author":"C Lindoff","year":"1997","unstructured":"Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B: Preeclampsia is associated with reduced response to activated protein C. Am J Obstet Gynecol. 1997, 176: 457-460.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000022502","volume":"29","author":"G Mello","year":"1999","unstructured":"Mello G, Parretti E, Martini E, Mecacci F, La Torre P, Cioni R, Lucchetti R, Fedi S, Gori AM, Pepe G, Prisco D, Abbate R: Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. Haemostasis. 1999, 29: 197-203. 10.1159\/000022502.","journal-title":"Haemostasis"},{"key":"111_CR71","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","volume":"81","author":"PG Lindqvist","year":"1999","unstructured":"Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B: Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost. 1999, 81: 532-537.","journal-title":"Thromb Haemost"},{"key":"111_CR72","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","volume":"181","author":"CJM De Groot","year":"1999","unstructured":"De Groot CJM, Bloemenkamp KWM, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, De Ronde H, Oei SG, Kanhai HHH, Rosendaal FR: Preeclampsia and genetic risk factors for thrombosis: a case control study. Am J Obstet Gynecol. 1999, 181: 975-980.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR73","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","volume":"87","author":"ER Morrison","year":"2002","unstructured":"Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA: Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost. 2002, 87: 779-785. Review","journal-title":"Thromb Haemost"},{"key":"111_CR74","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/01.ATV.20.1.266","volume":"20","author":"RP Murphy","year":"2000","unstructured":"Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, Fitzgerald DJ: Prospective evaluation of the risk conferred by factor V Leiden and the thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol. 2000, 20: 266-270.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"111_CR75","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1067\/mob.2001.110411","volume":"184","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, Merrill DC: Genetic susceptibility to pre-eclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-basepair insertion at nucleotide 844 of the gene for cystathione-synthase, and factor V Leiden mutation. Am J Obstet Gynecol. 2001, 184: 1211-1217. 10.1067\/mob.2001.110411.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1071-5576(98)00052-5","volume":"6","author":"RW Powers","year":"1999","unstructured":"Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM: Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Invest. 1999, 6: 74-79. 10.1016\/S1071-5576(98)00052-5.","journal-title":"J Soc Gynecol Invest"},{"key":"111_CR77","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1067\/mob.2001.109393","volume":"184","author":"AMA Lachmeijer","year":"2001","unstructured":"Lachmeijer AMA, Arngrimsson R, Bastiaans EJ, Pals G, ten Kate LP, de Vries JIP, Kostense PJ, Aarnoudse JG, Dekker GA: Mutations in the gene for MTHFR, homocysteine levels, and vitamin status in women with a history of PE. Am J Obstet Gynecol. 2001, 184: 394-402. 10.1067\/mob.2001.109393.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1081\/PRG-100101991","volume":"19","author":"PLM Zusterzeel","year":"2000","unstructured":"Zusterzeel PLM, Visser W, Blom HJ, Peters WHM, Heil SG, Steegers EAP: Methylenetetrahydrofolate reductase polymorphisms in pre-eclampsia and the HELLP syndrome. Hypertens Preg. 2000, 19: 299-307. 10.1081\/PRG-100101991.","journal-title":"Hypertens Preg"},{"key":"111_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000010291","volume":"50","author":"T Kaiser","year":"2000","unstructured":"Kaiser T, Brennecke SP, Moses EK: Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia\/eclampsia in Australian women. Gynecol Obstet Invest. 2000, 50: 100-102. 10.1159\/000010291.","journal-title":"Gynecol Obstet Invest"},{"key":"111_CR80","first-page":"23","volume":"19","author":"B Hauge","year":"2000","unstructured":"Hauge B, Wiltshire E, Nelson P, Dekker G, Robinson J, Thomas D: Polymorphisms of Methylenetetrahydrofolate reductase in women with pre-eclampsia 12th International society for the study of hypertension in pregnancy. Hypertens Pregnancy. 2000, 19: 23-abstract # O46","journal-title":"Hypertens Pregnancy"},{"key":"111_CR81","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0029-7844(97)00223-8","volume":"90","author":"A Rajkovic","year":"1997","unstructured":"Rajkovic A, Catlano PM, Malinow MR: Elevated homocysteine levels with preeclampsia. Obstet Gynecol. 1997, 90: 168-171. 10.1016\/S0029-7844(97)00223-8.","journal-title":"Obstet Gynecol"},{"key":"111_CR82","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ajcn\/71.4.962","volume":"71","author":"SE Vollset","year":"2000","unstructured":"Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM: Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr. 2000, 71: 962-968.","journal-title":"Am J Clin Nutr"},{"key":"111_CR83","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1067\/mob.2001.117304","volume":"185","author":"AM Cotter","year":"2001","unstructured":"Cotter AM, Molloy AM, Scott JM, Daly SF: Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol. 2001, 185: 781-785. 10.1067\/mob.2001.117304.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR84","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/meta.2000.6749","volume":"49","author":"CJ Glueck","year":"2000","unstructured":"Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T: The 4G\/4G polymorphism of the hypofibrinolytic PAI-1 gene: an independent risk factor for serious pregnancy complications. Metabolism. 2000, 49: 845-852. 10.1053\/meta.2000.6749.","journal-title":"Metabolism"},{"key":"111_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0029-7844(00)01094-2","volume":"97","author":"CJ Glueck","year":"2001","unstructured":"Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Eldor A: Increased Frequency of the Hypofibrinolytic 4G\/4G Polymorphism of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene in Women with Obstetric Complications. Obstet Gynecol. 2001, 97: 44-48. 10.1016\/S0029-7844(00)01094-2.","journal-title":"Obstet Gynecol"},{"issue":"1 Pt 1","key":"111_CR86","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0002-9378(95)90099-3","volume":"172","author":"BM Sibai","year":"1995","unstructured":"Sibai BM, Ramadan MK, Chari RS, Friedman SA: Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995, 172 (1 Pt 1): 125-129.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR87","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1067\/mob.2002.120280","volume":"186","author":"MD Hnat","year":"2002","unstructured":"Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, VanDorsten JP, Landon M, Miodovnik M, Paul R, Meis P, Thurnau G, Dombrowski M: Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002, 186: 422-426. 10.1067\/mob.2002.120280.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR88","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/S0002-9378(12)90773-5","volume":"165","author":"BM Sibai","year":"1991","unstructured":"Sibai BM, Mercer B, Sarinoglu C: Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991, 165: 1408-1412.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR89","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1471-0528.1997.tb10970.x","volume":"104","author":"JI de Vries","year":"1997","unstructured":"de Vries JI, Dekker GA, Huijgens PC, Jakobs C, Blomberg BM, van Geijn HP: Hyperhomocystinemia and protein S deficiency in complicated pregnancies. BJOG. 1997, 104: 1248-1254.","journal-title":"BJOG"},{"key":"111_CR90","first-page":"428","volume":"86","author":"P Martinelli","year":"2001","unstructured":"Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M, Di Minno G: Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica. 2001, 86: 428-431.","journal-title":"Haematologica"},{"key":"111_CR91","first-page":"177","volume":"87","author":"E Grandone","year":"2002","unstructured":"Grandone E, Margaglione M, Colaizzo D, Pavone G, Paladini D, Martinelli P, Di Minni G: low birth-weight in neonates of mothers carrying factor V G1691A and factor A 20210 mutations. Haematologica. 2002, 87: 177-181.","journal-title":"Haematologica"},{"key":"111_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1056\/NEJM200207043470105","volume":"347","author":"C Infante-Rivard","year":"2002","unstructured":"Infante-Rivard C, Rivard GE, Yotov WV, G\u00e9nin E, Guiguet M, Weinberg C, Gauthier R, Feoli-Fonseca JC: Absence of Association of Thrombophilia Polymorphisms with Intrauterine Growth Restriction. N Engl J Med. 2002, 347: 19-25. 10.1056\/NEJM200207043470105.","journal-title":"N Engl J Med"},{"key":"111_CR93","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0029-7844(01)01780-X","volume":"99","author":"R Reznik","year":"2002","unstructured":"Reznik R: Intrauterine growth restriction. Obstet Gynecol. 2002, 99: 490-496. 10.1016\/S0029-7844(01)01780-X.","journal-title":"Obstet Gynecol"},{"key":"111_CR94","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1046\/j.1471-0528.2002.02194.x","volume":"109","author":"MJ Kupferminc","year":"2002","unstructured":"Kupferminc MJ, Many A, Bar-Am A, Lessing JB, Landsberg JA: Mid-Trimester Severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. BJOG. 2002, 109: 1373-1376.","journal-title":"BJOG"},{"key":"111_CR95","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1471-0528.2000.tb13341.x","volume":"107","author":"EF van der Molen","year":"2000","unstructured":"van der Molen EF, Verbruggen B, Novakova I, Eskes TK, Monnens LA, Blom HJ: Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG. 2000, 107: 785-791.","journal-title":"BJOG"},{"key":"111_CR96","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0002-9378(98)70025-0","volume":"179","author":"Z Wiener-Megnagi","year":"1998","unstructured":"Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, Shalev E: Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol. 1998, 179: 1565-1567.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0301-2115(96)02383-4","volume":"66","author":"TA Goddijn-Wessel","year":"1996","unstructured":"Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, Boers GH, Eskes TK: Hyperhomocystinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol. 1996, 66: 23-29. 10.1016\/0301-2115(96)02383-4.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"111_CR98","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0165-0378(01)00144-9","volume":"55","author":"L Regan","year":"2002","unstructured":"Regan L, Rai R: Thrombophilia and pregnancy loss. J Reprod Immunol. 2002, 55: 163-180. 10.1016\/S0165-0378(01)00144-9. Review","journal-title":"J Reprod Immunol"},{"key":"111_CR99","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0140-6736(91)90205-4","volume":"337","author":"M Tulppala","year":"1991","unstructured":"Tulppala M, Viinikka L, Ylikorkala O: Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet. 1991, 337: 879-881. 10.1016\/0140-6736(91)90205-4.","journal-title":"Lancet"},{"key":"111_CR100","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0140-6736(98)85022-8","volume":"352","author":"T Vincent","year":"1998","unstructured":"Vincent T, Rai R, Regan L, Cohen H: Increased thrombin generation in women with recurrent miscarriage. Lancet. 1998, 352: 116-10.1016\/S0140-6736(98)85022-8.","journal-title":"Lancet"},{"key":"111_CR101","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0049-3848(89)90460-X","volume":"55","author":"J Woodhams","year":"1989","unstructured":"Woodhams J, Candotti G, Shaw R, Kernoff PBA: Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res. 1989, 55: 99-107.","journal-title":"Thromb Res"},{"key":"111_CR102","first-page":"168","volume":"15","author":"R Rai","year":"2000","unstructured":"Rai R, Tuddenham E, Backos M, Regan L: Pre-pregnancy thrombophilic abnormalities are associated with subsequent spontaneous abortion. Hum Reprod. 2000, 15: 168-","journal-title":"Hum Reprod"},{"key":"111_CR103","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","volume":"174","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996, 174: 1584-1589.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR104","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","volume":"314","author":"R Rai","year":"1997","unstructured":"Rai R, Cohen H, Dave M, Regan L: Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997, 314: 253-257.","journal-title":"BMJ"},{"key":"111_CR105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-0037-1614620","volume":"82","author":"B Brenner","year":"1999","unstructured":"Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N: Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost. 1999, 82: 6-9.","journal-title":"Thromb Haemost"},{"key":"111_CR106","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-2141.1997.882901.x","volume":"97","author":"B Brenner","year":"1997","unstructured":"Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z: Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol. 1997, 97: 551-554. 10.1046\/j.1365-2141.1997.882901.x.","journal-title":"Br J Haematol"},{"key":"111_CR107","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","volume":"128","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA: Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med. 1998, 128: 1000-1003.","journal-title":"Ann Intern Med"},{"key":"111_CR108","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.8755-8920.2000.430106.x","volume":"43","author":"JS Younis","year":"2000","unstructured":"Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M: Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol. 2000, 43: 31-35. 10.1111\/j.8755-8920.2000.430106.x.","journal-title":"Am J Reprod Immunol"},{"key":"111_CR109","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0015-0282(01)02971-5","volume":"77","author":"G Sarig","year":"2002","unstructured":"Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B: Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002, 77: 342-347. 10.1016\/S0015-0282(01)02971-5.","journal-title":"Fertil Steril"},{"key":"111_CR110","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/humrep\/14.6.1624","volume":"14","author":"J Tal","year":"1999","unstructured":"Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D: A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod. 1999, 14: 1624-1627. 10.1093\/humrep\/14.6.1624.","journal-title":"Hum Reprod"},{"key":"111_CR111","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ajh.10223","volume":"71","author":"RR Finan","year":"2002","unstructured":"Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY: Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol. 2002, 71: 300-305. 10.1002\/ajh.10223.","journal-title":"Am J Hematol"},{"key":"111_CR112","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/humrep\/15.2.458","volume":"15","author":"ZJ Foka","year":"2000","unstructured":"Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, Makris PE, Bontis J, Kotsis A: Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod. 2000, 15: 458-462. 10.1093\/humrep\/15.2.458.","journal-title":"Hum Reprod"},{"key":"111_CR113","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0306-5456(01)00298-4","volume":"108","author":"MF Reznikoff-Etievan","year":"2001","unstructured":"Reznikoff-Etievan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J: Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG. 2001, 108: 1251-1254. 10.1016\/S0306-5456(01)00298-4.","journal-title":"BJOG"},{"key":"111_CR114","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1067\/mob.2002.126849","volume":"187","author":"A Alonso","year":"2002","unstructured":"Alonso A, Soto I, Urgelles MF, Corte JR, Rodriguez MJ, Pinto CR: Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol. 2002, 187: 1337-1342. 10.1067\/mob.2002.126849.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR115","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/humrep\/16.5.961","volume":"16","author":"R Rai","year":"2001","unstructured":"Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, Regan L: Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod. 2001, 16: 961-965. 10.1093\/humrep\/16.5.961.","journal-title":"Hum Reprod"},{"key":"111_CR116","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0038-1656060","volume":"77","author":"E Grandone","year":"1997","unstructured":"Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, Di Minno G: Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost. 1997, 77: 822-824.","journal-title":"Thromb Haemost"},{"key":"111_CR117","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0015-0282(99)00133-8","volume":"71","author":"WH Kutteh","year":"1999","unstructured":"Kutteh WH, Park VM, Deitcher SR: Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 1999, 71: 1048-1053. 10.1016\/S0015-0282(99)00133-8.","journal-title":"Fertil Steril"},{"key":"111_CR118","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0165-0378(97)00039-9","volume":"34","author":"DS Dizon-Townson","year":"1997","unstructured":"Dizon-Townson DS, Kinney S, Branch DW, Ward K: The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol. 1997, 34: 217-223. 10.1016\/S0165-0378(97)00039-9.","journal-title":"J Reprod Immunol"},{"issue":"Suppl 1","key":"111_CR119","first-page":"117b","volume":"92","author":"SR Deitcher","year":"1998","unstructured":"Deitcher SR, Park VM, Kutteh WH: Methylene tetrahydrofolate reductase 677 T mutation analysis in Caucasian women with early first trimester recurrent pregnancy loss. Blood. 1998, 92 (Suppl 1): 117b-","journal-title":"Blood"},{"issue":"Suppl 1","key":"111_CR120","first-page":"121b","volume":"92","author":"A Kornberg","year":"1998","unstructured":"Kornberg A, Raziel A, Rahimini-Levene N, Yona R, Sela BA, Ron-El R: Hypercoagulability and recurrent abortions. Blood. 1998, 92 (Suppl 1): 121b-","journal-title":"Blood"},{"key":"111_CR121","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jn\/128.8.1336","volume":"128","author":"WL Nelen","year":"1998","unstructured":"Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers CH, Eskes TK: Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 1998, 128: 1336-1341.","journal-title":"J Nutr"},{"key":"111_CR122","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0015-0282(00)01595-8","volume":"74","author":"WL Nelen","year":"2000","unstructured":"Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK: Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000, 74: 1196-1199. 10.1016\/S0015-0282(00)01595-8.","journal-title":"Fertil Steril"},{"key":"111_CR123","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1093\/humrep\/14.10.2448","volume":"14","author":"SS Souza","year":"1999","unstructured":"Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF: Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod. 1999, 14: 2448-2450. 10.1093\/humrep\/14.10.2448.","journal-title":"Hum Reprod"},{"key":"111_CR124","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/107602960100700106","volume":"7","author":"W Pickering","year":"2001","unstructured":"Pickering W, Marriott K, Regan L: G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Hemost. 2001, 7: 25-28.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"Suppl 1","key":"111_CR125","first-page":"118b","volume":"92","author":"SR Deitcher","year":"1998","unstructured":"Deitcher SR, Park VM, Kutteh WH: Prothrombin 20210 G A mutation analysis in Caucasian women with early first trimester recurrent pregnancy loss. Blood. 1998, 92 (Suppl 1): 118b-","journal-title":"Blood"},{"key":"111_CR126","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.8755-8920.2001.460202.x","volume":"46","author":"R Pihusch","year":"2001","unstructured":"Pihusch R, Buchholz T, Lohse P, Rubsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ: Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol. 2001, 46: 124-131. 10.1111\/j.8755-8920.2001.460202.x.","journal-title":"Am J Reprod Immunol"},{"key":"111_CR127","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","volume":"75","author":"BJ Sanson","year":"1996","unstructured":"Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami A, ten Cate JW, Prins MH: The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost. 1996, 75: 387-388.","journal-title":"Thromb Haemost"},{"key":"111_CR128","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00062752-200009000-00006","volume":"7","author":"B Brenner","year":"2000","unstructured":"Brenner B: Inherited thrombophilia and fetal loss: Curr Opin. Hematol. 2000, 7: 290-295. 10.1097\/00062752-200009000-00006. Review","journal-title":"Hematol"},{"key":"111_CR129","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","volume":"348","author":"FE Preston","year":"1996","unstructured":"Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W: Increased fetal loss in women with heritable thrombophilia. Lancet. 1996, 348: 913-916. 10.1016\/S0140-6736(96)04125-6.","journal-title":"Lancet"},{"key":"111_CR130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614594","volume":"81","author":"JC Gris","year":"1999","unstructured":"Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daures JP, Mares P: Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent \u2013 the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost. 1999, 81: 891-899.","journal-title":"Thromb Haemost"},{"key":"111_CR131","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","volume":"343","author":"I Martinelli","year":"2000","unstructured":"Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM: Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000, 343: 1015-1018. 10.1056\/NEJM200010053431405.","journal-title":"N Engl J Med"},{"key":"111_CR132","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0029-7844(02)01938-5","volume":"99","author":"A Many","year":"2002","unstructured":"Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kupferminc MJ: Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol. 2002, 99: 684-687. 10.1016\/S0029-7844(02)01938-5.","journal-title":"Obstet Gynecol"},{"key":"111_CR133","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","volume":"361","author":"E Rey","year":"2003","unstructured":"Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003, 361: 901-9088. 10.1016\/S0140-6736(03)12771-7.","journal-title":"Lancet"},{"key":"111_CR134","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","volume":"83","author":"B Brenner","year":"2000","unstructured":"Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS: Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost. 2000, 83: 693-697.","journal-title":"Thromb Haemost"},{"key":"111_CR135","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","volume":"107","author":"JS Younis","year":"2000","unstructured":"Younis JS, Ohel G, Brenner B, Haddad S, Lanir N, Ben-Ami M: The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation. BJOG. 2000, 107: 415-419.","journal-title":"BJOG"},{"key":"111_CR136","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","volume":"322","author":"L Duley","year":"2001","unstructured":"Duley L, Henderson-Smart D, Knight M, King J: Antiplatelet drugs for prevention of pre-eclampsia and its consequences: Systematic review. BMJ. 2001, 322: 329-333. 10.1136\/bmj.322.7282.329.","journal-title":"BMJ"},{"key":"111_CR137","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1479-828X.1995.tb02141.x","volume":"35","author":"RA North","year":"1995","unstructured":"North RA, Ferrier C, Gamble G, Fairley KF, Kincaid-Smith P: Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol. 1995, 35: 357-362.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"111_CR138","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10641950109152640","volume":"20","author":"MJ Kupferminc","year":"2001","unstructured":"Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A: A Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypertens Pregnancy. 2001, 20: 35-44. 10.1081\/PRG-100104170.","journal-title":"Hypertens Pregnancy"},{"key":"111_CR139","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","volume":"80","author":"N Riyazi","year":"1998","unstructured":"Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA: Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol. 1998, 80: 49-54. 10.1016\/S0301-2115(98)00083-9.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"111_CR140","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0140-6736(98)10265-9","volume":"353","author":"IA Greer","year":"1999","unstructured":"Greer IA: Thrombosis in Pregnancy: Maternal and Fetal Issues. Lancet. 1999, 353: 4-10. 10.1016\/S0140-6736(98)10265-9.","journal-title":"Lancet"},{"key":"111_CR141","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0038-1657542","volume":"78","author":"U Seligsohn","year":"1997","unstructured":"Seligsohn U, Zivelin A: Thrombophilia As a Multigenic Disorder. Thromb Haemost. 1997, 78: 297-301.","journal-title":"Thromb Haemost"},{"key":"111_CR142","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/NEJM200002103420602","volume":"342","author":"A Gerhardt","year":"2000","unstructured":"Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB: Prothrombin and Factor V Mutations in Women With a History of Thrombosis During Pregnancy and the Puerperium. N Engl Med. 2000, 342: 374-380. 10.1056\/NEJM200002103420602.","journal-title":"N Engl Med"},{"key":"111_CR143","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJM200002103420610","volume":"342","author":"IA Greer","year":"2000","unstructured":"Greer IA: The Challenge of Thrombophilia in Maternal-Fetal Medicine. N Engl Med. 2000, 342: 424-425. 10.1056\/NEJM200002103420610.","journal-title":"N Engl Med"},{"key":"111_CR144","volume-title":"London: HMSO","author":"A Turnball","year":"1989","unstructured":"Turnball A, Tindall VR, Beard RW: Report on confidential enquiries into maternal death in England and Wales 1982\u20131984. London: HMSO. 1989, Report No:28"},{"key":"111_CR145","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0950-3552(97)80019-3","volume":"11","author":"IA Greer","year":"1997","unstructured":"Greer IA: Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. Baillieres Clin. Obstet Gynaecol. 1997, 11: 403-430.","journal-title":"Baillieres Clin. Obstet Gynaecol"},{"key":"111_CR146","first-page":"16","volume-title":"Maladie Thromboembolique Veineuse Chez La Femme Enceinte: Sang Thrombose Vaisseaux","author":"E Ferrari","year":"1999","unstructured":"Ferrari E, Jambou D, Fischer F, Appert-Flory A: Maladie Thromboembolique Veineuse Chez La Femme Enceinte: Sang Thrombose Vaisseaux. 1999, 11: 16-19."},{"key":"111_CR147","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bmj.1.5901.215","volume":"2","author":"MA Badracco","year":"1974","unstructured":"Badracco MA, Vessey M: Recurrence of Venous Thromboembolism and the Use of Oral Contraceptives. BMJ. 1974, 2: 215-217.","journal-title":"BMJ"},{"key":"111_CR148","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0038-1648485","volume":"67","author":"JS Ginsberg","year":"1992","unstructured":"Ginsberg JS, Brill-Edwards P, Burrows RF, Bona R, Prandoni P, Buller HR, Lensing A: Venous Thrombosis During Pregnancy: Leg and Trimester of Presentation. Thromb Haemost. 1992, 67: 519-520.","journal-title":"Thromb Haemost"},{"key":"111_CR149","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1471-0528.1997.tb11043.x","volume":"104","author":"NS Macklon","year":"1997","unstructured":"Macklon NS, Greer IA, Bowman AW: An Ultrasound Study of Gestational and Postural Changes in the Deep Venous System of the Leg in Pregnancy. Br J Obstet Gynaecol. 1997, 104: 191-197.","journal-title":"Br J Obstet Gynaecol"},{"key":"111_CR150","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615057","volume":"79","author":"P Clark","year":"1998","unstructured":"Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID: Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy. Thromb Haemost. 1998, 79: 1166-1170.","journal-title":"Thromb Haemost"},{"key":"111_CR151","first-page":"987","volume-title":"Haemostasis and thrombosis in pregnancy","author":"IA Greer","year":"1994","unstructured":"Greer IA: Haemostasis and thrombosis in pregnancy. Edited by: Bloom AL, Forbes CD, Thomas DP, and Tuddenham EGD. 1994, Edinburgh: Churchill Livingston, 987-999."},{"key":"111_CR152","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1471-0528.1970.tb04407.x","volume":"77","author":"JR Friend","year":"1970","unstructured":"Friend JR, Kakkar VV: The diagnosis of deep venous thrombosis in the puerperium. J Obstet Gynaecol Br Commonw. 1970, 77: 820-823.","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"111_CR153","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/003693309604100305","volume":"41","author":"NS Macklon","year":"1996","unstructured":"Macklon NS, Greer IA: Venous thromboembolic disease in obstetrics and gynaecology: the Scottish Experience. Scott Med. 1996, 41: 83-86.","journal-title":"Scott Med"},{"key":"111_CR154","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0038-1646557","volume":"61","author":"JS Ginsberg","year":"1989","unstructured":"Ginsberg JS, Hirsh J, Rainbow AJ, Coates G: Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost. 1989, 61: 189-196.","journal-title":"Thromb Haemost"},{"key":"111_CR155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0038-1642378","volume":"71","author":"G Finazzi","year":"1994","unstructured":"Finazzi G, Barbui T: Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S. Thromb Haemost. 1994, 71: 15-18.","journal-title":"Thromb Haemost"},{"key":"111_CR156","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","volume":"63","author":"J Conard","year":"1990","unstructured":"Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M: Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost. 1990, 63: 319-320.","journal-title":"Thromb Haemost"},{"key":"111_CR157","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","volume":"77","author":"BJ Hunt","year":"1997","unstructured":"Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N, Hughes G, Khamashta M: Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost. 1997, 77: 39-43.","journal-title":"Thromb Haemost"},{"key":"111_CR158","doi-asserted-by":"publisher","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","volume":"125","author":"PW Friederich","year":"1996","unstructured":"Friederich PW, Sanson BJ, Simioni P, Zanardi S, Huisman MV, Kindt I, Prandoni P, Buller HR, Girolami A, Prins MH: Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med. 1996, 125: 955-960.","journal-title":"Ann Intern Med"},{"key":"111_CR159","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0002-9378(97)70617-3","volume":"176","author":"M Hallak","year":"1997","unstructured":"Hallak M, Senderowicz J, Cassel A, Shapira C, Aghai E, Auslender R, Abramovici H: Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am J Obstet Gynecol. 1997, 176: 889-893.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR160","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1471-0528.1998.tb10241.x","volume":"105","author":"MD McColl","year":"1998","unstructured":"McColl MD, Walker ID, Greer IA: A Mutation in the prothrombin gene contributing to venous thrombosis during pregnancy. Br J Obstet Gynaecol. 1998, 105: 923-925.","journal-title":"Br J Obstet Gynaecol"},{"key":"111_CR161","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0037-1614222","volume":"79","author":"PG Lindqvist","year":"1998","unstructured":"Lindqvist PG, Svensson PJ, Dahlback B, Marsal K: Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss-a possible evolutionary selection mechanism. Thromb Haemost. 1998, 79: 69-73.","journal-title":"Thromb Haemost"},{"key":"111_CR162","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V90.5.1747","volume":"90","author":"FR Rosendaal","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL: A Common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood. 1997, 90: 1747-1750.","journal-title":"Blood"},{"key":"111_CR163","doi-asserted-by":"publisher","first-page":"524S","DOI":"10.1378\/chest.114.5_Supplement.524S","volume":"114","author":"JS Ginsberg","year":"1998","unstructured":"Ginsberg JS, Hirsh J: Use of Antithrombotic agents during pregnancy. Chest. 1998, 114: 524S-530S.","journal-title":"Chest"},{"key":"111_CR164","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","volume":"81","author":"BJ Sanson","year":"1999","unstructured":"Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, Dulitzky M, Nielsen JD, Boda Z: Low molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost. 1999, 81: 668-672.","journal-title":"Thromb Haemost"},{"key":"111_CR165","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","volume":"176","author":"C Nelson-Piercy","year":"1997","unstructured":"Nelson-Piercy C, Letsky EA, De Swiet M: Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol. 1997, 176: 1062-1068.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR166","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0038-1646338","volume":"68","author":"E Melissari","year":"1992","unstructured":"Melissari E, Parker CJ, Wilson NV, Monte G, Kanthou C, Pemberton KD, Nicolaides KH, Barrett JJ, Kakkar VV: Use of low molecular weight heparin in pregnancy. Thromb Haemost. 1992, 68: 652-656.","journal-title":"Thromb Haemost"},{"key":"111_CR167","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0020-7292(92)90261-G","volume":"39","author":"S Gillis","year":"1992","unstructured":"Gillis S, Shushan A, Eldor A: Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. Int Gynaecol Obstet. 1992, 39: 297-301.","journal-title":"Int Gynaecol Obstet"},{"key":"111_CR168","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00006254-199406000-00025","volume":"49","author":"MD Fejgin","year":"1994","unstructured":"Fejgin MD, Lourwood DL: Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv. 1994, 49: 424-431.","journal-title":"Obstet Gynecol Surv"},{"key":"111_CR169","first-page":"314","volume":"23","author":"J Harenberg","year":"1993","unstructured":"Harenberg J, Schneider D, Heilmann L, Wolf H: Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis. 1993, 23: 314-320.","journal-title":"Haemostasis"},{"key":"111_CR170","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-0037-1616134","volume":"86","author":"I Martinelli","year":"2001","unstructured":"Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM: Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost. 2001, 86: 800-803.","journal-title":"Thromb Haemost"},{"key":"111_CR171","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1259\/0007-1285-68-809-515","volume":"68","author":"NS Macklon","year":"1995","unstructured":"Macklon NS, Greer IA: Technical note: Compression stockings and posture: a comparative study of their effects on the proximal deep veins of the leg at rest. Br J Radiol. 1995, 68: 515-518.","journal-title":"Br J Radiol"},{"key":"111_CR172","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","volume":"343","author":"P Brill-Edwards","year":"2000","unstructured":"Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, Geerts W, Kovacs M, Weitz JI, Robinson KS, Whittom R, Couture G: Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000, 343: 1439-1444. 10.1056\/NEJM200011163432002.","journal-title":"N Engl J Med"},{"key":"111_CR173","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/0002-9378(95)91362-9","volume":"173","author":"LR Brancazio","year":"1995","unstructured":"Brancazio LR, Roperti KA, Stierer R, Laifer SA: Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol. 1995, 173: 1240-1245.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR174","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/0002-9378(95)90443-3","volume":"173","author":"LA Barbour","year":"1995","unstructured":"Barbour LA, Smith JM, Marlar RA: Heparin levels to guide thromboembolism prophylaxis during pregnancy. Am J Obstet Gynecol. 1995, 173: 1869-1873.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR175","doi-asserted-by":"publisher","first-page":"S336","DOI":"10.1053\/hj.1998.v135.90303","volume":"135","author":"J Hirsh","year":"1998","unstructured":"Hirsh J: Low-molecular-weight heparin for the treatment of venous thromboembolism. Am Heart J. 1998, 135: S336-S342.","journal-title":"Am Heart J"},{"key":"111_CR176","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0020-7292(94)90351-4","volume":"47","author":"C Rasmussen","year":"1994","unstructured":"Rasmussen C, Wadt J, Jacobsen B: Thromboembolic prophylaxis with low molecular weight heparin during pregnancy. Int Gynaecol Obstet. 1994, 47: 121-125.","journal-title":"Int Gynaecol Obstet"},{"key":"111_CR177","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","volume":"87","author":"M Dulitzki","year":"1996","unstructured":"Dulitzki M, Pauzner R, Langevitz P, Pras M, Many A, Schiff E: Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol. 1996, 87: 380-383. 10.1016\/0029-7844(95)00452-1.","journal-title":"Obstet Gynecol"},{"key":"111_CR178","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0002-9378(99)70091-8","volume":"181","author":"HL Casele","year":"1999","unstructured":"Casele HL, Laifer SA, Woelkers DA, Venkataramanan R: Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol. 1999, 181: 1113-1117.","journal-title":"Am J Obstet Gynecol"},{"key":"111_CR179","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/S0140-6736(05)60394-7","volume":"352","author":"AJ Thomson","year":"1998","unstructured":"Thomson AJ, Walker ID, Greer IA: Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy. Lancet. 1998, 352: 1904-","journal-title":"Lancet"},{"key":"111_CR180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/000313489906500214","volume":"65","author":"AF Aburahma","year":"1999","unstructured":"Aburahma AF, Boland JP: Management of Deep Vein Thrombosis of the lower extremity in pregnancy: a challenging dilemma. Am Surg. 1999, 65: 164-167.","journal-title":"Am Surg"},{"key":"111_CR181","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(05)76636-8","volume":"354","author":"M Greaves","year":"1999","unstructured":"Greaves M: Antiphospholipid antibodies and thrombosis [Letter, Comment]. Lancet. 1999, 354: 1031-","journal-title":"Lancet"},{"key":"111_CR182","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0037-1615891","volume":"82","author":"MD Lockshin","year":"1999","unstructured":"Lockshin MD: Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost. 1999, 82: 641-648.","journal-title":"Thromb Haemost"},{"key":"111_CR183","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","volume":"35","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH, Ermel LD: A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol. 1996, 35: 402-407.","journal-title":"Am J Reprod Immunol"},{"key":"111_CR184","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.51.6.1622","volume":"51","author":"DJ Lanska","year":"1998","unstructured":"Lanska DJ, Kryscio RJ: Stroke and Intracranial Venous Thrombosis During Pregnancy and Puerperium. Neurology. 1998, 51: 1622-1628.","journal-title":"Neurology"},{"key":"111_CR185","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004150050224","volume":"245","author":"JL Mas","year":"1998","unstructured":"Mas JL, Lamy C: Stroke in pregnancy and the puerperium. J Neurol. 1998, 245: 305-313. 10.1007\/s004150050224.","journal-title":"J Neurol"},{"key":"111_CR186","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJM199609123351102","volume":"335","author":"SJ Kittner","year":"1996","unstructured":"Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, Wityk RJ, Wozniak MA: Pregnancy and the risk of stroke. N Engl Med. 1996, 335: 768-774. 10.1056\/NEJM199609123351102.","journal-title":"N Engl Med"},{"key":"111_CR187","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/oxfordjournals.humrep.a137170","volume":"5","author":"B Rizk","year":"1990","unstructured":"Rizk B, Meagher S, Fisher AM: Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod. 1990, 5: 697-698.","journal-title":"Hum Reprod"},{"key":"111_CR188","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(89)91057-X","volume":"2","author":"R Kaaja","year":"1989","unstructured":"Kaaja R, Siegberg R, Tiitinen A, Koskimies A: Severe ovarian hyperstimulation syndrome and deep venous thrombosis [Letter]. Lancet. 1989, 2: 1043-10.1016\/S0140-6736(89)91057-X.","journal-title":"Lancet"},{"key":"111_CR189","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.STR.31.4.892","volume":"31","author":"MJ Kupferminc","year":"2000","unstructured":"Kupferminc MJ, Yair D, Bornstein NM, Lessing JB: Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia. Stroke. 2000, 31: 892-895.","journal-title":"Stroke"},{"key":"111_CR190","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1056\/NEJM199806183382510","volume":"338","author":"RM Bertina","year":"1998","unstructured":"Bertina RM, Rosendaal FR: Venous thrombosis-the Interaction of genes and environment. N Engl J Med. 1998, 338: 1840-1841. 10.1056\/NEJM199806183382510.","journal-title":"N Engl J Med"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-1-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:13:43Z","timestamp":1726240423000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-1-111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,14]]},"references-count":190,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-1-111","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,14]]},"assertion":[{"value":"31 March 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"111"}}